Boston Sci Misled Investors After Guidant Deal: Suit
Boston Scientific Corp. has been hit with a securities class action claiming that the company issued misleading information regarding its sales performance as the company dealt with product recalls and the...To view the full article, register now.
Already a subscriber? Click here to view full article